{"name":"Ospedale Santa Croce-Carle Cuneo","slug":"ospedale-santa-croce-carle-cuneo","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ESCALATED BEACOPP","genericName":"ESCALATED BEACOPP","slug":"escalated-beacopp","indication":"Hodgkin lymphoma","status":"phase_2"},{"name":"CONVENTIONAL ABVD","genericName":"CONVENTIONAL ABVD","slug":"conventional-abvd","indication":"Hodgkin lymphoma","status":"phase_2"}]}],"pipeline":[{"name":"ESCALATED BEACOPP","genericName":"ESCALATED BEACOPP","slug":"escalated-beacopp","phase":"phase_2","mechanism":"Beacopan is a monoclonal antibody that targets CD137, a member of the tumor necrosis factor receptor superfamily.","indications":["Hodgkin lymphoma"],"catalyst":""},{"name":"CONVENTIONAL ABVD","genericName":"CONVENTIONAL ABVD","slug":"conventional-abvd","phase":"phase_2","mechanism":"This chemotherapy regimen combines Adriamycin, Bleomycin, Vinblastine, and Dacarbazine to target rapidly dividing cancer cells.","indications":["Hodgkin lymphoma","Non-Hodgkin lymphoma"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}